Loss of CHCHD4 was shown to protect tumour cells from the growth inhibitory effects of CI inhibitors, whilst overexpression of CHCHD4 was shown to confer significant sensitivity to CI inhibitors, partly through increased mitochondrial ROS production [21] (Figure 3). This evidence concerns the gene CHCHD4 and neoplasm.